1. Siebel, G. L.; Kollman, P. A.Comprehensive Medicinal Chemistry: Quantitative Drug Design; Hansch, C., Sammes, P. G., Taylor, J. B., Ramdsen, C. A., Eds.; Pergamon: New York, 1990; Vol. IV, pp 125−138.
2. Weinstein, H.; Osman, R.; Green, J. P.; Olson, E. C.; Cristoffersen, R. E.Computer-Assisted Drug Design; ACS Symposium Series; American Chemical Society: Washington, DC, 1979; pp 161−170.
3. Hall, L. H.; Kier, L. B.Reviews in Computational Chemistry; Kipkowitz, K. B., Boyd, D. B., Eds.; VCH Publishers: New York, 1991; Vol. I, pp 367−422. Julián-Ortiz, J. V.; Gálvez, J.; Muñoz-Collado, C.; Garcáa-Domenech, R.; Gimeno-Cardona, C. Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds.J. Med. Chem.1999,42, 3308−3314. Basak, S. C.; Grunwald, G. D.; Niemi, G. I.ChemicalTopology to Three-Dimensional Geometry; Balaban, A. T., Eds.; Plenum Press: New York, 1997; pp 73−116. Estrada, E.; Pena, P.; Garcia-Domenech, R. Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach.J. Comput.Aided Mol.Des.1998,12, 583−595.